I agree that this site is using cookies. You can find further informations here.
X
van der Veldt, Astrid A M
~ 400  results:
Search for persons X
?
1

Cemiplimab in locally advanced or metastatic cutaneous squa..:

Verkerk, Karlijn ; Geurts, Birgit S. ; Zeverijn, Laurien J....
The Lancet Regional Health - Europe.  39 (2024)  - p. 100875 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Adjuvant treatment with anti‐PD‐1 in acral melanoma: A nati..:

Bloem, Manja ; van Not, Olivier J. ; Aarts, Maureen J. B....
International Journal of Cancer.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Review – The impact of pharmacogenetics on the outcome of i..:

de Joode, Karlijn ; Heersche, Niels ; Basak, Edwin A....
Cancer Treatment Reviews.  122 (2024)  - p. 102662 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Correlation between Histopathological Prognostic Tumor Char..:

Boers, Jorianne ; Eisses, Bertha ; Zwager, Mieke C....
Diagnostics.  14 (2024)  4 - p. 416 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Development and validation of a novel model to predict recu..:

Stassen, Robert C ; Maas, Carolien C H M ; van der Veldt, Astrid A M...
The Lancet Oncology.  25 (2024)  4 - p. 509-517 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Multi-omic analysis identifies hypoalbuminemia as independe..:

Leek, Lindsay V. M. ; Notohardjo, Jessica C. L. ; de Joode, Karlijn...
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
7

Evaluation of the tolerability and safety of [225Ac]Ac-PSMA..:

Ling, Sui wai ; van der Veldt, Astrid A. M. ; Konijnenberg, Mark...
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
8

BRAF/MEK inhibitor rechallenge in advanced melanoma patient:

Van Not, Olivier J. ; van den Eertwegh, Alfons J. M. ; Haanen, John B....
Cancer.  130 (2024)  9 - p. 1673-1683 , 2024
Link: https://doi.org/10.1002/..
 
?
9

Comprehensive characterization of circulating tumor cells a..:

Bos, Manouk K. ; Kraan, Jaco ; Starmans, Martijn P. A....
Molecular Oncology.  , 2024
Link: https://doi.org/10.1002/..
 
?
10

A prediction model for response to immune checkpoint inhibi..:

van Duin, Isabella A. J. ; Verheijden, Rik J. ; van Diest, Paul J....
International Journal of Cancer.  154 (2024)  10 - p. 1760-1771 , 2024
Link: https://doi.org/10.1002/..
 
?
11

The development of brain metastases in patients with differ..:

Derks, Sophie H. A. E. ; van der Meer, Edgar L. ; Joosse, Arjen...
International Journal of Cancer.  , 2024
Link: https://doi.org/10.1002/..
 
?
12

Corticosteroids and other immunosuppressants for immune-rel..:

Verheijden, Rik J. ; Burgers, Femke H. ; Janssen, Josephine C....
European Journal of Cancer.  207 (2024)  - p. 114172 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) sco..:

Rijnders, Maud ; Nakauma-González, J. Alberto ; Robbrecht, Debbie G. J....
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
14

Safe Stop IPI-NIVO trial: early discontinuation of nivoluma..:

Janssen, J. C. ; van Dijk, B. ; de Joode, K....
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
15

Whole-genome mapping of APOBEC mutagenesis in metastatic ur..:

Nakauma-González, J. Alberto ; Rijnders, Maud ; Noordsij, Minouk T.W....
Cell Genomics.  4 (2024)  4 - p. 100528 , 2024
Link: https://doi.org/10.1016/..
 
1-15